As pharma awaits FDA rules, marketing happens

Novo Nordisk's marketing partnership with diabetic race car driver Charlie Kimball is one of the most provocative examples of how pharmaceutical companies are cleverly navigating the emerging, largely unregulated social-media space. Report

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.